Profilo
Eric Olson is Chief Business Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc. since 2025.
Formerly, Mr. Olson was Chief Business Officer at Stoke Therapeutics, Inc. and Vice President & Head-Business Development at Alnylam Pharmaceuticals, Inc. Education includes undergraduate studies at Connecticut College, graduate studies at New York University, and an MBA from the University of Virginia Darden School of Business.
Posizioni attive di Eric Olson
| Società | Posizione | Inizio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 22/09/2025 |
Precedenti posizioni note di Eric Olson
| Società | Posizione | Fine |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Eric Olson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Connecticut College
Connecticut College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
















